Viewing Study NCT05468632


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-02-19 @ 8:20 AM
Study NCT ID: NCT05468632
Status: COMPLETED
Last Update Posted: 2023-02-14
First Post: 2022-07-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)
Sponsor: Novo Nordisk A/S
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: NN9535-4976
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators